FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL
Season 10, Episode 9, Jan 25, 2024, 07:55 PM
Share
Subscribe
Dr Davids discusses the FDA approval of pirtobrutinib for patients with previously treated CLL/SLL; key efficacy and safety data from the BRUIN trial; and guidelines for pirtobrutinib use in clinical practice in the CLL/SLL patient population.